These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19245976)

  • 1. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial.
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ
    J Am Coll Cardiol; 2009 Mar; 53(9):812-3. PubMed ID: 19245976
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.
    Syed AI; Ben-Dor I; Collins SD; Gonzalez MA; Gaglia MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2010 Feb; 23(1):33-9. PubMed ID: 20465718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes].
    Byrne R; Iijima R; Mehilli J; Pache J; Schulz S; Schömig A; Kastrati A
    Rev Esp Cardiol; 2008 Nov; 61(11):1134-9. PubMed ID: 19000488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
    J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial.
    Räber L; Wohlwend L; Wigger M; Togni M; Wandel S; Wenaweser P; Cook S; Moschovitis A; Vogel R; Kalesan B; Seiler C; Eberli F; Lüscher TF; Meier B; Jüni P; Windecker S
    Circulation; 2011 Jun; 123(24):2819-28, 6 p following 2828. PubMed ID: 21646500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A; Brodsky A; Sabapathy R; Pershad A
    Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the optimal treatment for elderly patients: lessons from real-world data.
    Meier P; Gurm HS
    J Invasive Cardiol; 2009 Jul; 21(7):334-5. PubMed ID: 19571344
    [No Abstract]   [Full Text] [Related]  

  • 8. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
    Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2007 Nov; 50(21):2037-8. PubMed ID: 18021869
    [No Abstract]   [Full Text] [Related]  

  • 10. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.
    Nikolsky E; Lansky AJ; Sudhir K; Doostzadeh J; Cutlip DE; Piana R; Su X; White R; Simonton CA; Stone GW
    Am Heart J; 2009 Oct; 158(4):520-526.e2. PubMed ID: 19781409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year outcomes of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: are they equally good (or bad)?
    Cutlip DE
    Circulation; 2011 Jun; 123(24):2779-81. PubMed ID: 21646497
    [No Abstract]   [Full Text] [Related]  

  • 12. Status of drug-eluting coronary stents.
    Chodosh A; Korr KS; Burtt D
    Med Health R I; 2008 Oct; 91(10):309-12, 314. PubMed ID: 19044106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stents for the treatment of acute myocardial infarction: the view to the HORIZONS.
    Prasad SB; Ahmar W; Malaiapan Y; Meredith IT
    Heart Lung Circ; 2010 Jan; 19(1):11-8. PubMed ID: 20022808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stents for the treatment of in-stent restenosis: a clinical review.
    Yan BP; Ajani AE; Waksman R
    Cardiovasc Revasc Med; 2005; 6(1):38-43. PubMed ID: 16263355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: a comparison with paclitaxel-eluting stents: the PORI registry.
    Karjalainen PP; Ylitalo A; Airaksinen JK; Nammas W
    J Interv Cardiol; 2011 Feb; 24(1):1-8. PubMed ID: 21039884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry.
    Onuma Y; Kukreja N; Piazza N; Eindhoven J; Girasis C; Schenkeveld L; van Domburg R; Serruys PW;
    J Am Coll Cardiol; 2009 Jul; 54(3):269-76. PubMed ID: 19589442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation.
    Moreno R; Fernandez C; Sanchez-Recalde A; Calvo L; Galeote G; Sanchez-Aquino R; Lopez-Sendon JL
    Br J Clin Pharmacol; 2007 Jul; 64(1):110-2. PubMed ID: 17577390
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The present and future of drug-eluting stents.
    Indolfi C; Mongiardo A; Spaccarotella C; Ferraro A; Torella D
    Ital Heart J; 2005 Jun; 6(6):498-506. PubMed ID: 16008155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.